Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis

  • Authors:
    • Sachiko Shioya
    • Takeshi Masuda
    • Tadashi Senoo
    • Yasushi Horimasu
    • Shintaro Miyamoto
    • Taku Nakashima
    • Hiroshi Iwamoto
    • Kazunori Fujitaka
    • Hironobu Hamada
    • Noboru Hattori
  • View Affiliations / Copyright

    Affiliations: Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734‑8551, Japan, Department of Respiratory Internal Medicine, Hiroshima University Hospital, Hiroshima 734‑8551, Japan, Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima 734‑8551, Japan, Department of Physical Analysis and Therapeutic Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734‑8551, Japan
    Copyright: © Shioya et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3070-3076
    |
    Published online on: August 1, 2018
       https://doi.org/10.3892/etm.2018.6550
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Radiation‑induced pulmonary fibrosis is a serious complication. Plasminogen activator inhibitor‑1 (PAI‑1) has been indicated to be a key factor in the progression of pulmonary fibrosis. In the present study, the effect of PAI‑1 deficiency on radiation‑induced pulmonary fibrosis was analyzed. Wild‑type (WT) and PAI‑1‑deficient (PAI‑1‑/‑) mice were treated with thoracic irradiation of 15 Gy to induce pulmonary fibrosis. Analyses of bronchoalveolar lavage (BAL) fluids were performed 0, 4, 12, 18, and 24 weeks after irradiation. The degree of pulmonary fibrosis was assessed according to the histology of lung tissues and hydroxyproline contents. The results demonstrated that the irradiation of WT mice increased PAI‑1 expression in the lungs after 18 weeks and established lung fibrosis at 24 weeks. The number of total cells and transforming growth factor‑β levels in BAL fluid were significantly lower at 24 weeks after irradiation in PAI‑1‑/‑ mice compared with WT mice. Furthermore, histological examination revealed that the extent of pulmonary fibrosis was attenuated in PAI‑1‑/‑ mice compared with that in WT mice. Hydroxyproline content was also significantly lower in PAI‑1‑/‑ mice compared with WT mice at 24 weeks after irradiation. In conclusion, PAI‑1 serves an important role in the development of radiation‑induced pulmonary fibrosis and may represent a novel therapeutic target for pulmonary fibrosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Ding NH, Li JJ and Sun LQ: Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets. 14:1347–1356. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Madani I, De Ruyck K, Goeminne H, De Neve W, Thierens H and Van Meerbeeck J: Predicting risk of radiation-induced lung injury. J Thorac Oncol. 2:864–874. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Rübe CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, Willich N and Rube C: Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys. 47:1033–1042. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR and Vaughn DJ: ASCO Cancer Survivorship Expert Panel: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects. J Clin Oncol. 25:3991–4008. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Rubin P, Johnston CJ, Williams JP, McDonald S and Finkelstein JN: A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 33:99–109. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Kohler HP and Grant PJ: Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med. 342:1792–1801. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Ghosh AK and Vaughan DE: PAI-1 in tissue fibrosis. J Cell Physiol. 227:493–507. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Iwaki T, Urano T and Umemura K: PAI-1, progress in understanding the clinical problem and its aetiology. Br J Haematol. 157:291–298. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D and Simon RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 97:232–237. 1996. View Article : Google Scholar : PubMed/NCBI

10 

Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH and Drew AF: Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest. 106:1341–1350. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Senoo T, Hattori N, Tanimoto T, Furonaka M, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Yokoyama A and Kohno N: Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis. Thorax. 65:334–340. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Omori K, Hattori N, Senoo T, Takayama Y, Masuda T, Nakashima T, Iwamoto H, Fujitaka K, Hamada H and Kohno N: Inhibition of plasminogen activator inhibitor-1 attenuates transforming growth factor-β-dependent epithelial mesenchymal transition and differentiation of fibroblasts to myofibroblasts. PLoS One. 11:e01489692016. View Article : Google Scholar : PubMed/NCBI

13 

Hageman J, Eggen BJ, Rozema T, Damman K, Kampinga HH and Coppes RP: Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res. 11:5956–5964. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Zhao W, Spitz DR, Oberley LW and Robbins ME: Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation. Cancer Res. 61:5537–5543. 2001.PubMed/NCBI

15 

Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE and Fogo AB: Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int. 58:1219–1227. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Oikawa T, Freeman M, Lo W, Vaughan DE and Fogo A: Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 51:164–172. 1997. View Article : Google Scholar : PubMed/NCBI

17 

Vozenin-Brotons MC, Milliat F, Linard C, Strup C, François A, Sabourin JC, Lasser P, Lusinchi A, Deutsch E, Girinsky T, et al: Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization. Radiat Res. 161:299–311. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Suzuki N, Ohta K, Horiuchi T, Takizawa H, Ueda T, Kuwabara M, Shiga J and Ito K: T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice. Thorax. 51:1036–1042. 1996. View Article : Google Scholar : PubMed/NCBI

19 

Chung EJ, McKay-Corkum G, Chung S, White A, Scroggins BT, Mitchell JB, Mulligan-Kehoe MJ and Citrin D: Truncated plasminogen activator inhibitor-1 protein protects from pulmonary fibrosis mediated by irradiation in a murine model. Int J Radiat Oncol Biol Phys. 94:1163–1172. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Lee JG, Shim S, Kim MJ, Myung JK, Jang WS, Bae CH, Lee SJ, Kim KM, Jin YW, Lee SS and Park S: Pentoxifylline regulates plasminogen activator inhibitor-1 expression and protein kinase A phosphorylation in radiation-induced lung fibrosis. Biomed Res Int. 2017:12792802017.PubMed/NCBI

21 

Travis EL, Rachakonda G, Zhou X, Korhonen K, Sekhar KR, Biswas S and Freeman ML: NRF2 deficiency reduces life span of mice administered thoracic irradiation. Free Radic Biol Med. 51:1175–1183. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Anscher MS, Thrasher B, Zgonjanin L, Rabbani ZN, Corbley MJ, Fu K, Sun L, Lee WC, Ling LE and Vujaskovic Z: Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 71:829–837. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Flechsig P, Dadrich M, Bickelhaupt S, Jenne J, Hauser K, Timke C, Peschke P, Hahn EW, Gröne HJ, Yingling J, et al: LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals. Clin Cancer Res. 18:3616–3627. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Liu RM: Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal. 10:303–319. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Schultze-Mosgau S, Kopp J, Thorwarth M, Rödel F, Melnychenko I, Grabenbauer GG, Amann K and Wehrhan F: Plasminogen activator inhibitor-I-related regulation of procollagen I (alpha1 and alpha2) by antitransforming growth factor-beta1 treatment during radiation-impaired wound healing. Int J Radiat Oncol Biol Phys. 64:280–288. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Seo JY, Park J, Yu MR, Kim YS, Ha H and Lee HB: Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Am J Nephrol. 30:481–490. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Nicholas SB, Aguiniga E, Ren Y, Kim J, Wong J, Govindarajan N, Noda M, Wang W, Kawano Y, Collins A and Hsueh WA: Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int. 67:1297–1307. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Allen GB, Cloutier ME, Larrabee YC, Tetenev K, Smiley ST and Bates JH: Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 296:L277–L285. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Huang Y, Zhang W, Yu F and Gao F: The cellular and molecular mechanism of radiation-induced lung injury. Med Sci Monit. 23:3446–3450. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Sgalla G, Iovene B, Calvello M, Ori M, Varone F and Richeldi L: Idiopathic pulmonary fibrosis: Pathogenesis and management. Respir Res. 19:322018. View Article : Google Scholar : PubMed/NCBI

31 

Betensley A, Sharif R and Karamichos D: A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis. J Clin Med. 6:pii: E2. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Burman A, Tanjore H and Blackwell TS: Endoplasmic reticulum stress in pulmonary fibrosis. Matrix Biol. 68–69:355–365. 2018. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shioya S, Masuda T, Senoo T, Horimasu Y, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N, Hattori N, et al: Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis. Exp Ther Med 16: 3070-3076, 2018.
APA
Shioya, S., Masuda, T., Senoo, T., Horimasu, Y., Miyamoto, S., Nakashima, T. ... Hattori, N. (2018). Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis. Experimental and Therapeutic Medicine, 16, 3070-3076. https://doi.org/10.3892/etm.2018.6550
MLA
Shioya, S., Masuda, T., Senoo, T., Horimasu, Y., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., Hattori, N."Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis". Experimental and Therapeutic Medicine 16.4 (2018): 3070-3076.
Chicago
Shioya, S., Masuda, T., Senoo, T., Horimasu, Y., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., Hattori, N."Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3070-3076. https://doi.org/10.3892/etm.2018.6550
Copy and paste a formatted citation
x
Spandidos Publications style
Shioya S, Masuda T, Senoo T, Horimasu Y, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N, Hattori N, et al: Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis. Exp Ther Med 16: 3070-3076, 2018.
APA
Shioya, S., Masuda, T., Senoo, T., Horimasu, Y., Miyamoto, S., Nakashima, T. ... Hattori, N. (2018). Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis. Experimental and Therapeutic Medicine, 16, 3070-3076. https://doi.org/10.3892/etm.2018.6550
MLA
Shioya, S., Masuda, T., Senoo, T., Horimasu, Y., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., Hattori, N."Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis". Experimental and Therapeutic Medicine 16.4 (2018): 3070-3076.
Chicago
Shioya, S., Masuda, T., Senoo, T., Horimasu, Y., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., Hattori, N."Plasminogen activator inhibitor‑1 serves an important role in radiation‑induced pulmonary fibrosis". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3070-3076. https://doi.org/10.3892/etm.2018.6550
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team